Literature DB >> 21786323

Urinary κ and λ immunoglobulin light chains in normoalbuminuric type 2 diabetes mellitus patients.

S B Hassan1, M O F Hanna.   

Abstract

BACKGROUND AND AIM: Kidney disease is one of the major chronic microvascular complications of diabetes. Tubular involvement may precede glomerular involvement and the appearance of microalbuminuria. The aim of the study was to evaluate quantitatively immunoglobulin light chains (IgLCs), kappa and lambda excretion in the urine of patients with type 2 diabetes mellitus with normoalbuminuria and with microalbuminuria compared to control group.
RESULTS: Urinary IgLCs levels of the control group were significantly lower than diabetic patients with normoalbuminuria and diabetic patients with albuminuria. IgLCs were significantly associated with the duration of disease and negatively with estimated glomerular filtration rate.
CONCLUSION: Type 2 diabetic patients can have significantly raised concentrations of urinary IgLCs before microalbuminuria or renal disease occurs. Further investigations are recommended to assess LC evaluation in the early management of diabetic renal disease.
© 2011 Wiley-Liss, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21786323      PMCID: PMC6647630          DOI: 10.1002/jcla.20463

Source DB:  PubMed          Journal:  J Clin Lab Anal        ISSN: 0887-8013            Impact factor:   2.352


  18 in total

1.  Clinical and laboratory profile of patients with type 2 diabetes with low glomerular filtration rate and normoalbuminuria.

Authors:  Caroline K Kramer; Cristiane B Leitão; Lana C Pinto; Sandra P Silveiro; Jorge L Gross; Luís H Canani
Journal:  Diabetes Care       Date:  2007-04-27       Impact factor: 19.112

2.  Light-chain binding sites on renal brush-border membranes.

Authors:  V Batuman; A W Dreisbach; J Cyran
Journal:  Am J Physiol       Date:  1990-05

Review 3.  Tubular changes in early diabetic nephropathy.

Authors:  M C Thomas; W C Burns; M E Cooper
Journal:  Adv Chronic Kidney Dis       Date:  2005-04       Impact factor: 3.620

Review 4.  Markers of diabetic nephropathy.

Authors:  C Y Hong; K S Chia
Journal:  J Diabetes Complications       Date:  1998 Jan-Feb       Impact factor: 2.852

5.  Considerations about the threshold value of microalbuminuria in patients with diabetes mellitus: lessons from an 8-year follow-up study of 599 patients.

Authors:  R Rachmani; Z Levi; M Lidar; I Slavachevski; E Half-Onn; M Ravid
Journal:  Diabetes Res Clin Pract       Date:  2000-08       Impact factor: 5.602

6.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with type II diabetes: an early marker of diabetic kidney disease?

Authors:  Colin A Hutchison; Paul Cockwell; Steven Harding; Graham P Mead; Arthur R Bradwell; Anthony H Barnett
Journal:  Expert Opin Ther Targets       Date:  2008-06       Impact factor: 6.902

Review 7.  Searching for novel biomarkers and new therapeutic targets of diabetic nephropathy using proteomics approaches.

Authors:  Visith Thongboonkerd
Journal:  Contrib Nephrol       Date:  2008       Impact factor: 1.580

8.  Quantitative assessment of serum and urinary polyclonal free light chains in patients with chronic kidney disease.

Authors:  Colin A Hutchison; Stephen Harding; Pete Hewins; Graham P Mead; John Townsend; Arthur R Bradwell; Paul Cockwell
Journal:  Clin J Am Soc Nephrol       Date:  2008-11       Impact factor: 8.237

9.  Nonalbuminuric renal insufficiency in type 2 diabetes.

Authors:  Richard J MacIsaac; Con Tsalamandris; Sianna Panagiotopoulos; Trudy J Smith; Karen J McNeil; George Jerums
Journal:  Diabetes Care       Date:  2004-01       Impact factor: 19.112

Review 10.  Early nephropathy in type 1 diabetes: the importance of early renal function decline.

Authors:  Bruce A Perkins; Andrzej S Krolewski
Journal:  Curr Opin Nephrol Hypertens       Date:  2009-05       Impact factor: 2.894

View more
  2 in total

1.  Audit of the Prevalence of Noncorrelation of Immunofixation with Protein Electrophoresis and Serum Free Light Chain Assays in Multiple Myeloma in a Tertiary Cancer Care Center.

Authors:  Chandramallika Paul; Subhosmito Chakraborty; S Sugumar; Ranjan Bhattacharya; Sandip Rath; Sarit Chakraborty
Journal:  Indian J Clin Biochem       Date:  2020-09-15

2.  Association between urinary free light chains and progression to end stage renal disease in chronic kidney disease.

Authors:  Anthony Fenton; Mark D Jesky; Rachel Webster; Stephanie J Stringer; Punit Yadav; Iain Chapple; Indranil Dasgupta; Stephen J Harding; Charles J Ferro; Paul Cockwell
Journal:  PLoS One       Date:  2018-05-09       Impact factor: 3.240

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.